经皮冠状动脉介入治疗术后出血风险评估研究进展

Bleeding Risk Assessment After Percutaneous Coronary Intervention

经皮冠状动脉介入治疗(PCI)是一种广泛应用的获得心肌血运重建的策略。PCI术后的抗栓治疗已成为治疗冠心病的基石,能有效防止支架内血栓形成和缺血事件的发生。然而与抗栓治疗相关的各种出血并发症也成为关注的热点。目前已有多个出血评分系统可用于预测患者在不同时期的出血风险,指导临床医生更全面地评估PCI术后出血风险,改善患者预后。现将出血风险评估模型结合其临床应用及最新研究进展做一综述,为临床实践提供参考。

Percutaneous coronary intervention(PCI)is a widely adopted strategy to obtain myocardial revascularization in patients.Antithrombotic therapy after PCI has become the cornerstone of drug therapy for acute coronary syndrome,which can effectively prevent stent thrombosis and ischemic events.However,various bleeding complications related to antithrombotic therapy have also become a hot spot of concern.At present,several bleeding scoring systems can be used to predict the bleeding risk of patients at different periods,guide clinicians to more comprehensively evaluate the bleeding risk after PCI,and improve the prognosis of patients.This article reviews the bleeding risk assessment model combined with its clinical application and the latest research progress,so as to provide reference for clinical practice.